Applications are open for Stem Cell Network’s Incubation Investment Award Program!
Funding will be deployed through SCN’s Incubation Investment Award (IIA) Program - designed to advance pre-seed and seed-staged Canadian regenerative medicine (RM) companies. SCN’s investment program will support high-potential biotechs by enabling the generation of critical data packages to attract third-party investment and accelerate company growth. Investments will range from $250,000 to $1 million per company, with funds released in tranches over a two-to-three-year period and contingent on the achievement of defined scientific and business milestones.
Stage 1 applications will close on Friday, September 26, 2025, at 11:59 p.m. PT.
